Jazz Pharmaceuticals
JAZZ | NASDAQ
$215.98
+$8.15 (+3.92%)
At close: Oct 30, 2026, 4:00 PM ET
$216.93
+$0.95 (+0.44%)
Pre-market:
Nov 2, 2026, 9:28 AM ET
Market Data
Market Cap $14.02B
Enterprise Value $16.23B
Beta 0.32
Average Volume 852.04K
Shares Outstanding (Diluted) 69.4M
Shares Change YoY 13.41%
Institutional Ownership N/A
Exchange NASDAQ
ISIN IE00B4Q5ZN47
Price Performance
Price Change 1M -6.7%
Price Change 3M -14.6%
Price Change 6M 6.5%
Price Change YTD 27.1%
Price Change 1Y 56.9%
Price Change 3Y 70.0%
Price Change 5Y 62.3%
1M CAGR (ann.) -10.3%
1Y CAGR (ann.) 59.1%
5Y CAGR (ann.) 8.3%
All-Time CAGR 7.0%
Valuation
PE Ratio 14.76
Forward PE 7.96
PEG Ratio 0.00
Forward PEG 0.20
PS Ratio 3.05
Forward PS 2.80
PB Ratio 2.92
P/FCF Ratio 9.09
P/Adj. FCF Ratio 12.67
P/OCF Ratio 8.22
EV/Sales 3.53
EV/EBIT 17.60
EV/EBITDA 10.99
EV/FCF 10.52
Earnings Yield 6.8%
FCF Yield 11.0%
Adj. FCF Yield 7.9%
Financial Health
Net Debt $2.15B
Total Debt $4.41B
Cash & Short-Term Investments $2.2B
Total Assets $11.08B
Current Ratio 1.78
Quick Ratio 1.58
Debt / Equity Ratio 0.92
Debt / EBITDA 2.99
Debt / FCF 2.86
OCF / Debt 0.38
Interest Coverage 7.35
Altman Z-Score 2.36
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 84.7%
Operating Profit Margin 31.1%
EBITDA Margin 35.6%
Net Profit Margin 20.4%
FCF Margin 33.5%
Adj. FCF Margin 24.1%
SBC / Revenue 9.5%
SBC Impact (per share) -28.2%
Returns
Return on Assets 8.5%
Return on Equity 21.4%
Return on Invested Capital 14.5%
Return on Capital Employed 16.1%
Return on Tangible Assets 17.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 6.9%
Revenue CAGR 5Y 11.9%
Revenue CAGR 10Y 12.6%
EPS CAGR 3Y 96.3%
EPS CAGR 5Y 72.8%
EPS CAGR 10Y 9.8%
FCF CAGR 3Y 4.2%
FCF CAGR 5Y 15.4%
FCF CAGR 10Y 14.5%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 14
EPS Growth Next 3Y 29.4%
Revenue Growth Next 3Y 9.4%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$4.05
EPS Growth Est (next Q) -149.8%
Revenue Est (next Q) $1.21B
Revenue Growth Est (next Q) 7.3%
Fair Value Estimates
Graham Number $158.15
Graham Upside -26.8%
Lynch Fair Value $365.75
Lynch Upside 69.3%
Price Target $292.27
Price Target Upside 35.3%
Cash Flow
Operating Cash Flow $1.66B
Free Cash Flow $1.54B
Adj. Free Cash Flow $1.11B
FCF Per Share $24.40
OCF Per Share $26.28
OCF/S Ratio 36.1%
Income Statement
Revenue $4.6B
Gross Profit $3.9B
Operating Income $1.43B
EBITDA $1.48B
Net Income $940.76M
EPS (Diluted) $14.63
Revenue / Employee $1.59M
Profit / Employee $325.52K
Employees 2,890
Add to Watchlist
Select watchlists to add or remove JAZZ